Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
P02 ANTHELMINTICS
P02B ANTITREMATODALS
P02BX Other antitrematodal agents
P02BX04 Triclabendazole
D07364 Triclabendazole (USAN/INN) <US>
USP drug classification [BR:br08302]
Antiparasitics
Anthelmintics
Triclabendazole
D07364 Triclabendazole (USAN/INN)
Animal drugs in Japan [BR:br08331]
97 Agents against pathogenic micro-organisms and parasites (except biological products and disinfectants)
975 Anthelmintics for digestive organs
9752 Thiabendazole derivatives and preparations
D07364 Triclabendazole
Antimicrobials [BR:br08307]
Antiparasitics
Antitrematodal agents
Others
D07364 Triclabendazole (USAN/INN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D07364
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D07364
Other DBs
CAS:
68786-66-3
PubChem:
51091701
PDB-CCD:
JA9[PDBj]
LigandBox:
D07364
NIKKAJI:
J126.317J
KCF data
ATOM 21
1 C8y C 15.2600 -16.5200
2 C8x C 15.2600 -17.9200
3 C8x C 16.4724 -18.6200
4 C8x C 17.6849 -17.9200
5 C8y C 17.6849 -16.5200
6 C8y C 16.4724 -15.8200
7 X Cl 16.4724 -14.4202
8 X Cl 14.0476 -15.8200
9 O2a O 18.9160 -15.8090
10 C8y C 20.1212 -16.5047
11 C8y C 20.1216 -17.9196
12 C8x C 21.3342 -18.6193
13 C8y C 22.5465 -17.9189
14 C8y C 22.5460 -16.5039
15 C8x C 21.3334 -15.8043
16 N5x N 23.8923 -18.3558
17 C8y C 24.7237 -17.2108
18 N4x N 23.8916 -16.0663
19 X Cl 18.8858 -18.6340
20 S2a S 26.1100 -17.2104
21 C1a C 26.8144 -18.4299
BOND 23
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 6 7 1
8 1 8 1
9 5 9 1
10 9 10 1
11 10 11 2
12 11 12 1
13 12 13 2
14 13 14 1
15 14 15 2
16 10 15 1
17 13 16 1
18 16 17 2
19 17 18 1
20 14 18 1
21 11 19 1
22 17 20 1
23 20 21 1